October 28, 2021
  • The Federal Trade Commission (FTC) ordered DaVita to divest itself of three Utah dialysis clinics. The order requires DaVita sell the clinics to Sanderling Renal Services and prohibits DaVita from applying noncompete agreements with University of Utah physicians, restricting Sanderling Renal Services from soliciting DaVita employees, and directly soliciting patients who receive services from the three divested clinics for a period of two years. The company must also adhere to a 10-year requirement to seek prior approval for any future acquisitions within the state. (Article here)